The National Institutes of Health (NIH) awarded a $1,710,000.00 Project Grant to the Salk Institute for Biological Studies in La Jolla, California under the Trans-NIH Research Support program (CFDA 93.310). The purpose of this 3-year grant, effective September 22, 2023, is to develop novel tools and model systems to track the dynamic interactions between rapid signaling, stress and metabolic responses, transcriptional changes, epigenetic modifications, and genetic alterations that contribute to acquired resistance to anti-cancer therapies targeting the cellular autophagy process. This research aims to improve understanding of resistance mechanisms and facilitate the development of more effective autophagy-targeting cancer treatments.
Generated 7/16/24, 5:31 AM